1
项与 NK cell(Shenzhen University General Hospital) 相关的临床试验Clinical Study of Decitabine Combined With NK Cell Infusion in the Treatment of Malignant Tumors
Natural killer cells (NK cells) are derived from bone marrow lymphoid stem cells, which are a type of lymphocytes that can non-specifically kill tumor cells and virus-infected cells without pre-sensitization. NK cells can not only directly kill malignant diseased cells, but also participate in the regulation of immune cell response and play a role in a variety of tumor immunotherapy strategies. The 2-year survival rate of NK cells combined with stem cell therapy for patients with hematological malignancies reached 36%, which is significantly higher than the 2-year survival rate (about 15%) of stem cell therapy alone, which can extend the disease-free survival period of leukemia patients by an average of 1.5 years. Relapsed and refractory leukemia can achieve a complete remission rate of up to 40%.
100 项与 NK cell(Shenzhen University General Hospital) 相关的临床结果
100 项与 NK cell(Shenzhen University General Hospital) 相关的转化医学
100 项与 NK cell(Shenzhen University General Hospital) 相关的专利(医药)
100 项与 NK cell(Shenzhen University General Hospital) 相关的药物交易